The report "Pressure Monitoring Market by Product (Oximeters, BP Cuffs, BP Monitors (Digital, Aneroid, Cuffless)), Procedure (Invasive & Non-invasive), Therapeutic Application (Respiratory and Cardiac Disorders, Glaucoma), End User - Global Forecast to 2032", pressure monitoring market is projected to reach USD 25.48 billion by 2032 from USD 14.56 billion in 2025, at a CAGR of 8.3% from 2025 to 2032.
Browse 588 market data Tables and 59 Figures spread through 484 Pages and in-depth TOC on "Pressure Monitoring Market by Product (Oximeters, BP Cuffs, BP Monitors (Digital, Aneroid, Cuffless)), Procedure (Invasive & Non-invasive), Therapeutic Application (Respiratory and Cardiac Disorders, Glaucoma), End User - Global Forecast to 2032"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pressure-monitoring-market-196787732.html
The pressure monitoring market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements, and changing healthcare needs. Conditions such as hypertension, cardiovascular diseases, and respiratory disorders are becoming more common, which necessitates regular and accurate pressure monitoring for effective management.
Innovations in non-invasive, portable, and digital monitoring devices have made it easier for both patients and healthcare providers to track vital signs in clinical and home settings. Additionally, the aging global population and an increased awareness of preventive healthcare are further accelerating the demand for these devices.
The expansion of telemedicine, along with supportive government initiatives, improved healthcare infrastructure, and a greater adoption of remote monitoring systems, is also reinforcing the growth of the market.
Based on products, the blood pressure monitoring segment accounted for the largest share of the pressure monitoring market in 2024.
The blood pressure monitoring devices market is experiencing significant growth, driven by several interconnected factors. The primary factor is the rising global prevalence of hypertension and cardiovascular diseases, which require regular monitoring for effective management. According to the World Health Organization, approximately 1.28 billion adults aged 30–79 worldwide have hypertension, highlighting the urgent need for accessible monitoring solutions.
Technological advancements have led to the development of user-friendly, portable, and smart devices that enable home-based monitoring, which is in line with the increasing trend of telehealth and self-care. The integration of features such as Bluetooth connectivity and mobile applications allows for real-time data tracking and sharing with healthcare providers, improving patient engagement and adherence to treatment plans.
Based on procedure type, the non-invasive procedures segment held the largest share of the pressure monitoring market in 2024.
The increasing demand for non-invasive procedures is a major factor driving growth in the pressure monitoring market. This trend is fueled by a growing preference for patient comfort, a reduced risk of complications, and quicker recovery times.
Non-invasive pressure monitoring devices avoid the need for penetration or catheterization, making them safer and more suitable for frequent or long-term use, particularly in outpatient and home care settings. Technological innovations have improved the accuracy and reliability of these devices, promoting their use in clinical and personal healthcare environments.
Additionally, the rise in chronic diseases, an aging population, and the global shift toward preventive and remote healthcare are further increasing the demand for non-invasive monitoring solutions.
Based on therapeutic applications, the cardiovascular disorders segment held the largest share of the pressure monitoring market in 2024.
Cardiovascular disorders significantly drive growth in the pressure monitoring market due to their high prevalence worldwide and the essential need for continuous blood pressure management among affected individuals. Conditions such as hypertension, heart failure, and arrhythmias necessitate regular monitoring to prevent complications like stroke or cardiac arrest. This makes pressure monitoring devices vital for both diagnosis and long-term care.
As lifestyle-related risk factors—such as poor diet, physical inactivity, and stress—continue to rise globally, the burden of cardiovascular diseases increases as well. This trend, along with heightened healthcare awareness and advancements in wearable and home-based monitoring technologies, is significantly boosting the demand for pressure monitoring solutions in both clinical and personal health settings.
The hospitals segment accounted for the largest share of the pressure monitoring market in 2024.
Hospitals are crucial to the growth of the pressure monitoring market due to the necessity for accurate, real-time monitoring of patients in critical and acute care settings. In emergency departments, intensive care units (ICUs), and operating rooms, continuous monitoring of blood pressure, intraocular pressure, and intracranial pressure is essential for managing life-threatening conditions such as trauma, stroke, cardiac arrest, and post-surgical recovery. The rising number of hospital admissions related to chronic conditions like hypertension and cardiovascular diseases further increases the demand for advanced monitoring systems.
Hospitals also benefit from integrated monitoring platforms that streamline workflows, reduce manual errors, and enhance patient outcomes, making these systems indispensable to modern healthcare delivery. Furthermore, the growing emphasis on patient safety and adherence to clinical guidelines has driven hospitals to adopt high-precision, automated pressure monitoring devices. The need for early diagnosis and prevention of complications, combined with an aging population that requires more frequent hospitalization, has accelerated the adoption of these technologies.
Technological advancements, such as wireless connectivity, interoperability with electronic health records (EHRs), and AI-driven analytics, have made hospital-based pressure monitoring more efficient and scalable. Additionally, government support, favorable reimbursement policies, and investments in hospital infrastructure across both developed and emerging markets are further propelling the demand for pressure monitoring equipment in the hospital sector.
In 2024, North America accounted for the largest share of the pressure monitoring market.
The pressure monitoring market in North America is experiencing rapid growth due to the high prevalence of chronic diseases such as hypertension, cardiovascular disorders, and respiratory illnesses. These conditions necessitate consistent and accurate monitoring of blood pressure and other vital parameters, particularly among aging populations who are more susceptible to these health issues. The rise in lifestyle-related health problems, driven by poor diet, sedentary behavior, and stress, has further amplified the demand for early detection and ongoing management, boosting the need for advanced pressure monitoring solutions.
Technological advancements are also significantly contributing to the market's growth. North America is leading the way in integrating digital health tools, including wireless and wearable pressure monitoring devices that enable real-time tracking and remote care. The increasing acceptance of telemedicine and home healthcare, especially following the COVID-19 pandemic, has encouraged patients to use self-monitoring devices. Additionally, continuous innovation from leading market players, supportive government initiatives, and growing awareness of preventive healthcare collectively accelerate the adoption of pressure monitoring systems throughout the region.
Key Market Players
The key players in the pressure monitoring market are Medtronic (US), Omron Corporation (Japan), Dragerwerk AG & Co. KGaA (Germany), Abbott (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Baxter (US), Terumo Corporation (Japan), BD (US), Nihon Kohden Corporation (Japan), Integra LifeSciences Corporation (US), Zeiss Group (Germany), Boston Scientific Corporation (US), HONSUN (China), A&D Company (Japan), Reichert, Inc. (US), Nonin (US), Mehra Eyetech Pvt. Ltd. (India), Rossmax International Ltd. (China), Microlife Corporation. (China), SunTech Medical, Inc. (US), PAUL HARTMANN Asia-Pacific Ltd. (Canada), Icare Finland Oy (Finland), and iHealth Labs Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/